18 results
Thumbnail

D2.296 - Heat-Stable Egg Allergens in a Patient With Severe Reactions to Cooked and Raw Hen’s Egg

Thumbnail

D2.298 - Diagnostic performance of skin prick testing with fresh and frozen cow's milk in addition to commercial extract in cow’s milk allergy

Thumbnail

D2.300 - Food allergy and food sensitization in children with Netherton syndrome

Thumbnail

D2.290 - Curcubitaceae allergy, a new enemy identificated in Watermelon

Thumbnail

D2.291 - Trends and Patterns Observed Among Suspected Egg-allergic Children in Hong Kong: A 26-year Retrospective Study

Thumbnail

D2.292 - Effects of Milk Oral Immunotheraphy on Human Basophils in Children with Cow’s Milk Protein Allergy

Thumbnail

D2.293 - Differential Clinical Implications of Peach Allergen Components Pru p 3 and Pru p 7

Thumbnail

D2.294 - Clinical Characteristics of Food-Allergic Children with Peripheral Blood Hypereosinophilia

Thumbnail

D2.299 - ARFID: The Hidden Face of Food Allergy?

Thumbnail

D2.301 - High Prevalence of Familial Meat Allergy on the Black Sea Coast: Insights into Alpha-Gal Syndrome

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria

Thumbnail

D3.426 - Predicting response to omalizumab in patients with chronic spontaneous urticaria: The first results of the global multicenter UCARE SCOPUS project

Thumbnail

D3.427 - Challenging the paradigm: Use of omalizumab in refractory angioedema in a 2-year-old child

Thumbnail

D3.428 - Substratification of Biologic Treatment Using Dupilumab in Eosinophilic COPD

Thumbnail

D3.417 - Dupilumab in pediatric patients with severe atopic dermatitis